About NaDeNo Nanoscience
NaDeNo Nanoscience is a company based in Trondheim (Norway) founded in 2022.. NaDeNo Nanoscience offers products and services including PACAB-002 and Tailored Nanoformulations. NaDeNo Nanoscience operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Revolution Medicines, among others.
- Headquarter Trondheim, Norway
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nadeno Nanoscience As
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NaDeNo Nanoscience
NaDeNo Nanoscience offers a comprehensive portfolio of products and services, including PACAB-002 and Tailored Nanoformulations. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Encapsulates Cabazitaxel for targeted cancer treatment delivery.
Provides solutions for hydrophobic drugs in oncology applications.
Funding Insights of NaDeNo Nanoscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by NaDeNo Nanoscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NaDeNo Nanoscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nadeno Nanoscience Comparisons
Competitors of NaDeNo Nanoscience
NaDeNo Nanoscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Revolution Medicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about NaDeNo Nanoscience
When was NaDeNo Nanoscience founded?
NaDeNo Nanoscience was founded in 2022.
Where is NaDeNo Nanoscience located?
NaDeNo Nanoscience is headquartered in Trondheim, Norway. It is registered at Trondheim, Trøndelag, Norway.
What does NaDeNo Nanoscience do?
NaDeNo Nanoscience was founded in 2022 in Trondheim, Norway. Operations are centered on the development of nanotechnology-based therapeutics targeting cancer. Research and innovation in nanoscience are conducted to advance drug delivery systems. The focus remains on biotechnology and pharmaceutical sectors, with activities aimed at creating effective treatments for oncology applications. Geographic operations are based in Norway, supporting collaborative efforts in the region.
Who are the top competitors of NaDeNo Nanoscience?
NaDeNo Nanoscience's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does NaDeNo Nanoscience offer?
NaDeNo Nanoscience offers PACAB-002 and Tailored Nanoformulations.